1417P Comparative efficacy and safety of tislelizumab versus anti-PD-1 treatments in second-line esophageal squamous cell carcinoma: Simulated treatment comparisons

Autor: Smyth, E.C., Ajani, J.A., Wang, K., Coaquira Castro, J., Figueiredo, M., Sun, J-M., Soulanis, K., Tasoulas, A., Nikolaidis, G., Priedane, E., Zhan, L.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S884-S884
Databáze: ScienceDirect